SCHEMBL8265879

SCHEMBL8265879

CN1CCN(c2ncc(C(=O)N(Cc3ccncc3)C3CC3)c(C3=C(F)CCC=C3)n2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TACR1 P25103 2/20 0.41
▸ ALDH1A1 P00352 10/20 0.35
▸ CYP3A4 P08684 9/20 0.35
▸ HSD17B10 Q99714 8/20 0.35
▸ CYP1A2 P05177 8/20 0.35
▸ CASP1 P29466 8/20 0.35
▸ CASP7 P55210 8/20 0.35
▸ USP2 O75604 8/20 0.35
▸ HIF1A Q16665 7/20 0.35
▸ CYP2C9 P11712 3/20 0.35
▸ CYP2C19 P33261 3/20 0.35
▸ GLA P06280 5/20 0.34
▸ CYP2D6 P10635 2/20 0.33
▸ TSHR P16473 4/20 0.33
▸ MAPK1 P28482 4/20 0.33
▸ LMNA P02545 2/20 0.33
▸ TP53 P04637 2/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11923175 0.83 TACR1 (0.52) TACR1ALDH1A1CYP3A4HSD17B10CYP1A2
SCHEMBL8267713 0.82 KMT2A (0.41) ALDH1A1CYP3A4CYP1A2CASP1CASP7
SCHEMBL8267716 0.80 AGER (0.40) ALDH1A1CYP3A4HSD17B10CYP1A2CASP1
SCHEMBL8265883 0.77 TACR1 (0.54) TACR1ALDH1A1CYP3A4HSD17B10CYP1A2
SCHEMBL8265839 0.76 TACR1 (0.53) TACR1ALDH1A1CYP3A4HSD17B10CYP1A2
SCHEMBL11923250 0.75 TACR1 (0.58) TACR1ALDH1A1CYP3A4HSD17B10CASP1
SCHEMBL8267741 0.75 PTPN11 (0.30) —
SCHEMBL8267738 0.74 TACR1 (0.53) TACR1ALDH1A1CYP3A4HSD17B10CYP1A2
SCHEMBL8266035 0.74 TACR1 (0.53) TACR1ALDH1A1CYP3A4HSD17B10CYP1A2
SCHEMBL11923299 0.73 TACR1 (0.41) TACR1ALDH1A1CYP3A4HSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006050476-A2 PYRIMIDINE DERIVATIVES AS ION CHANNEL MODULATORS AND METHODS OF USE VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-05-11 — — WO disclosed
Send feedback